Stockholder's Equity (Tables)

9 Months Ended

Sep. 30, 2022

TardiMed

STOCKHOLDERS' DEFICIT

Schedule of warrants outstanding

				Weighted
				Average
	Shares	Weighted		Remaining	Aggregate
	Underlying	Average		Contractual	Intrinsic
	TardiMed Warrant	Exercise Price		Term (Years)	Value
Outstanding as of December 31, 2021	—	$	—	*	$	—
Issued	181,083	$	0.005	*	$	1,085,590
Exercised	(36,217)	$	0.005	*	$	(217,118)
Outstanding and exercisable as of September 30, 2022	144,866	$	0.005	*	$	868,472
* Options expire once fully exercised; until exercised there is no expiration term

Series A Warrants

STOCKHOLDERS' DEFICIT

Schedule of warrants outstanding

				Weighted
				Average
	Shares	Weighted		Remaining	Aggregate
	Underlying	Average		Contractual	Intrinsic
	Warrants	Exercise Price		Term (Years)	Value
Outstanding as of December 31, 2021	334,036	$	58.00	3.4		—
Outstanding and exercisable as of September 30, 2022	334,036	$	58.00	2.7	$	—

Series B Warrants

STOCKHOLDERS' DEFICIT

Schedule of warrants outstanding

	Shares	Weighted		Aggregate
	Underlying	Average		Intrinsic
	Warrants	Exercise Price		Value
Outstanding as of January 1, 2020	149,481	$	0.05	$	7,474
Exercised	(149,481)	$	0.05		—
Outstanding and exercisable as of September 30, 2021	—	$	—	$	—

Bridge warrants

STOCKHOLDERS' DEFICIT

Schedule of warrants outstanding

				Weighted
				Average
	Shares	Weighted		Remaining	Aggregate
	Underlying	Average		Contractual	Intrinsic
	Warrants	Exercise Price		Term (Years)	Value
Outstanding as of December 31, 2021	8,275	$	1.00	3.4	$	28,963
Outstanding and exercisable as of September 30, 2022	8,275	$	1.00	2.6	$	41,375

November 2021

STOCKHOLDERS' DEFICIT

Schedule of warrants outstanding

				Weighted
				Average
	Shares	Weighted		Remaining	Aggregate
	Underlying	Average		Contractual	Intrinsic
	Warrants	Exercise Price		Term (Years)	Value
Outstanding as of December 31, 2021	539,063	$	35.00	4.8	$	7,101,563
Outstanding and exercisable as of September 30, 2022	539,063	$	35.00	4.1	$	7,101,563

August 2022 Common Stock Warrants

STOCKHOLDERS' DEFICIT

Schedule of warrants outstanding

				Weighted
				Average
	Shares	Weighted		Remaining	Aggregate
	Underlying	Average		Contractual	Intrinsic
	Warrants	Exercise Price		Term (Years)	Value
Outstanding as of December 31, 2021	—	$	—	—	$	—
Granted	1,333,333	$	6.00	4.9	$	4,933,333
Exercised	(24,000)	$	6.00	—	$	(88,800)
Outstanding and exercisable as of September 30, 2022	1,309,333	$	6.00	4.9	$	4,844,533